NovAccess Global Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In USD, except per-share amounts

	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021	FY2020 12 months to Sep 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss
Adjustment to reconcile net loss to net cash used in operating activities
Amortization of debt discount and debt issuance costs recorded as interest expense
Amortization of debt discount recorded as interest expense
Loss on conversion of Preferred Stock
Loss (Gain) on change in derivative liability
Loss on change in fair value of derivative liability
Loss on derivatives
Extinguishment of derivatives
Imputed interest on related party loan
Stock issued and issuable for services
Stock based compensation
Warrants issued for loan extension
Fair value of commitment shares issued for loans
Impairment of investment

Changes in Assets and Liabilities:
Employee advances
Prepaid expenses
Accounts payable
Other payable
Accrued legal settlement
Accrued expenses and other current liabilities
Accrued payroll
Deferred compensation
License fees payable

NET CASH USED IN OPERATING ACTIVITIES - CONTINUING OPERATIONS
NET CASH PROVIDED BY OPERATING ACTIVITIES - DISCONTINUED OPERATIONS
NET CASH USED IN OPERATING ACTIVITIES
Investment in StemVax, LLC
Purchase of fixed asset - discontinued operations
NET CASH USED IN INVESTING ACTIVITIES - DISCONTINUED OPERATIONS
CASH FLOWS FROM FINANCING ACTIVITIES:
Stock subscriptions received
Due to related party
Payments to related party for redemption of preferred stock
Payments of promissory notes
Proceeds from bridge loans payable - related parties
Payments on related party loan
Proceeds from promissory notes
Proceeds from convertible notes payable to related parties
Payment on the bridge loans payable – related parties
Payments on convertible promissory notes
Proceeds from short term loans payable - related parties
NET CASH PROVIDED BY FINANCING ACTIVITIES

NET CASH USED BY INVESTING ACTIVITIES
NET DECREASE IN CASH
CASH, BEGINNING OF PERIOD
CASH, BEGINNING OF PERIOD
CASH, END OF PERIOD
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON-CASH TRANSACTIONS
Net impact of preferred stock redemption transaction
Shares issued for StemVax acquisition - from stock payable
Common stock issued on conversion of convertible note
Accrued interest capitalized into convertible note
Debt discount on new issuances
Accrued interest capitalized into convertible notes
Initial derivative recognition on new loans and warrants
Common stock issued to purchase long-term equity investment
Common stock issued as commitment fee on promissory note

Comments